Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-11-15

Clinical Trial Update: Treatment of Helminth co-Infection: Short-Term Effects on HIV-1 Progression Markers and Immune Activation [NA]

View source ↗

Summary

A completed clinical trial evaluated the short-term effects of treating helminth co-infection on HIV-1 progression markers and immune activation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Washington | Conditions: HIV Infections, Helminthiasis | NA | Status: COMPLETED